Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 7,291 | 10,038 | 12,444 | 10,519 | 10,630 |
| Cost of Goods | 7,016 | 10,190 | 10,907 | 7,191 | 2,731 |
| Gross Profit | 275 | -152 | 1,537 | 3,328 | 7,899 |
| Operating Expenses | 22,846 | 27,548 | 25,133 | 32,956 | 31,293 |
| Operating Income | -22,555 | -27,510 | -22,689 | -29,437 | -22,663 |
| Interest Expense | 69 | 0 | 0 | 0 | 0 |
| Other Income | 137 | -70 | -134 | 156 | 188 |
| Pre-tax Income | -22,487 | -27,580 | -22,823 | -29,281 | -22,475 |
| Net Income Continuous | -22,487 | -27,580 | -22,823 | -29,281 | -22,475 |
| Net Income | $-22,487 | $-27,580 | $-22,823 | $-29,281 | $-22,475 |
| EPS Basic Total Ops | -0.40 | -0.50 | -0.41 | -0.54 | -0.42 |
| EPS Basic Continuous Ops | -0.40 | -0.50 | -0.41 | -0.54 | -0.42 |
| EPS Diluted Total Ops | -0.40 | -0.50 | -0.41 | -0.54 | -0.42 |
| EPS Diluted Continuous Ops | -0.40 | -0.50 | -0.41 | -0.54 | -0.42 |
| EBITDA(a) | $-20,831 | $-25,881 | $-21,182 | $-27,996 | $-21,276 |